Cerivastatin inhibits inducible NO synthase and ameliorates end-organ damage in rats with high human renin hypertension.

被引：0
|
作者：
Park, JK
Muller, DN
Mervaala, EMA
Schmidt, F
Bieringer, M
Schunck, WH
Ganten, D
Haller, H
Luft, FC
机构：
[1] Franz Volhard Clin, Berlin, Germany
[2] Max Delbruck Ctr Mol Med, Berlin, Germany
来源：
HYPERTENSION | 1999年 / 34卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：701 / 701
页数：1
相关论文
共 49 条
  • [21] Application of TNF receptor ameliorates cardiac and renal end-organ damage in Ang II-dependent hypertension independent of blood pressure
    Dechend, R
    Muller, DN
    Park, JK
    Mulally, A
    Dietz, R
    Luft, FC
    EUROPEAN HEART JOURNAL, 2002, 23 : 175 - 175
  • [22] Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats
    Vanêcková, I
    Kramer, HJ
    Bäcker, A
    Vernerová, Z
    Opocensky, M
    Cervenka, L
    HYPERTENSION, 2005, 46 (04) : 969 - 974
  • [23] Genetically high plasma angiotensinogen potentiates L-NAME induced Hypertension and promotes cardio-vascular end-organ damage in transgenic rats
    Bohlender, Juergen
    Gudo, Beatrice
    SWISS MEDICAL WEEKLY, 2013, 143 : 5S - 5S
  • [24] Application of a soluble TNF receptor ameliorates cardiac and renal end-organ damage in Ang II-dependent hypertension independent of blood pressure
    Müller, DN
    Dechend, R
    Park, JK
    Mervaala, E
    Fiebeler, A
    Haller, H
    Luft, FC
    JOURNAL OF HYPERTENSION, 2002, 20 : S93 - S93
  • [25] Androgen receptor deficiency attenuates hypertension and end-organ damage in transgenic rats harboring the mouse Ren-2 gene
    Baltatu, O
    Cayla, C
    Jordan, C
    Andreev, D
    Bader, M
    HYPERTENSION, 2000, 36 (04) : 671 - 671
  • [26] Chronic administration of the soluble epoxide hydrolase (sEH) inhibitor, AUDA, ameliorates end-organ damage in stroke-prone hypertensive rats (SHRSP)
    Li, Jing
    Carroll, Mairead A.
    Chander, Praveen N.
    Li, Yanna
    Falck, John R.
    Hammock, Bruce D.
    Stier, Charles T., Jr.
    FASEB JOURNAL, 2008, 22
  • [27] Effects of chronic cytochrome P-450 inhibition on the course of hypertension and end-organ damage in Ren-2 transgenic rats
    Chabova, Vera Certikova
    Kramer, Herbert J.
    Vaneckova, Ivana
    Vernerova, Zdena
    Eis, Vaclav
    Tesar, Vladimir
    Skaroupkova, Petra
    Thumova, Monika
    Schejbalova, Stanislava
    Huskova, Zuzana
    Vanourkova, Zdenka
    Kolsky, Alexander
    Imig, John D.
    Cervenka, Ludek
    VASCULAR PHARMACOLOGY, 2007, 47 (2-3) : 145 - 159
  • [28] AT1 receptor blockade is superior to conventional triple therapy in protecting against end-organ damage in Cyp1a1 Ren-2 transgenic rats with inducible hypertension
    Vanourkova, Zdenka
    Kramer, Herbert J.
    Huskova, Zuzana
    Vaneckova, Ivana
    Opocensky, Martin
    Chabova, Vera Certikova
    Tesar, Vladimir
    Skaroupkova, Petra
    Thumova, Monika
    Dohnalova, Michaela
    Mullins, John J.
    Cervenka, Ludek
    JOURNAL OF HYPERTENSION, 2006, 24 (12) : 2465 - 2472
  • [29] Role of the Renin-Angiotensin-Aldosterone System beyond Blood Pressure Regulation: Molecular and Cellular Mechanisms Involved in End-Organ Damage during Arterial Hypertension
    Munoz-Durango, Natalia
    Fuentes, Cristobal A.
    Castillo, Andres E.
    Martin Gonzalez-Gomez, Luis
    Vecchiola, Andrea
    Fardella, Carlos E.
    Kalergis, Alexis M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)
  • [30] Abolition of hypertension-induced end-organ damage by androgen receptor blockade in transgenic rats harboring the mouse Ren-2 gene
    Baltatu, O
    Cayla, C
    Iliescu, R
    Andreev, D
    Jordan, C
    Bader, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (11): : 2681 - 2687
12345